Paul Tudor Jones Abbott Laboratories Put Options Transaction History

Tudor Investment Corp Et Al

6 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2024 May 15, 2024	BUY	$109.52 - $120.96 $1.52 Million - $1.68 Million	13,900 Added 165.48%	22,300 $2.53 Million
Q4 2023 Feb 14, 2024	SELL	$90.19 - $110.4 $550,159 - $673,440	-6,100 Reduced 42.07%	8,400 $924,000
Q3 2023 Nov 15, 2023	BUY	$95.53 - $114.62 $38,212 - $45,848	400 Added 2.84%	14,500 $1.4 Million
Q2 2023 Aug 14, 2023	BUY	$100.78 - $112.29 $604,680 - $673,740	6,000 Added 74.07%	14,100 $1.54 Million
Q1 2023 May 15, 2023	SELL	$96.86 - $114.01 $426,184 - $501,644	-4,400 Reduced 35.2%	8,100 $820,000

Q4 2022 Feb 14, 2023	BUY	$95.06 - $111.52 $1.19 Million - $1.39 Million	12,500 New	12,500 $1.37 Million

3,127

1.29B

8.43M

8.71M

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $185B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

Get notified when there are updates to the investment portfolio of Tudor Investment Corp Et Al, based on Form 13F filings with the SEC.

Stay updated on Tudor Investment Corp Et Al and Paul Tudor Jones with notifications on news.